Insmed Inc. (INSM) Drops 6.2% on January 15

Equities Staff |

Insmed Inc. (INSM) was one of the Russell 2000's biggest losers for Friday January 15 as the stock slid 6.2% to $14.22, a loss of $-0.94 per share. Starting at an opening price of $14.64 a share, the stock traded between $13.85 and $14.72 over the course of the trading day. Volume was 382,120 shares over 4,738 trades, against an average daily volume of 540,652 shares and a total float of 61.8 million.

The losses send Insmed Inc. down to a market cap of $878.85 million. In the last year, Insmed Inc. has traded between $28.66 and $13.97, and its 50-day SMA is currently $17.00 and 200-day SMA is $21.50.

Insmed Inc is a biopharmaceutical company engaged in developing and commercializing inhaled therapies for patients battling serious lung diseases that are often life threatening. Its products candidates includes ARIKAYCE.

Insmed Inc. is based out of Bridgewater, NJ and has some 89 employees. Its CEO is William Lewis.

For a complete fundamental analysis analysis of Insmed Inc., check out’s Stock Valuation Analysis report for INSM. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Reliq Health Technologies Inc.

Moseda Technologies Inc provides mobile and IT cloud computing to increase operational efficiency and security. It develops SmartFleet, a solution designed for commercial use, as well as SmartCare, a mHealth…

Private Markets


Wealthfront is an automated investment service that serves as an alternative to traditional financial advisory services. The company manages a diversified, continually rebalanced portfolio of index funds on their clients’…


Uber connects riders with safe, reliable, convenient transportation providers at a variety of price-points in cities around the world. Uber makes money from charging their drivers 20% of the fare…